Din Natasha, Allen Isabel Elaine, Satariano William A, Demb Joshua, Braithwaite Dejana
Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
School of Public Health, University of California, Berkeley, CA, USA.
Breast Dis. 2016 Jul 28;36(2-3):77-89. doi: 10.3233/BD-150202.
To determine the association of prediagnostic alcohol consumption with long-term mortality from breast cancer and other causes in a cohort of women with breast cancer.
We studied a Michigan-based cohort of 939 women aged 40-84 years, who provided complete information about the type, amount and intensity of prediagnostic alcohol consumption. Associations of alcohol consumption, based on weekly volume of alcohol consumption during the year prior to breast cancer diagnosis, with mortality were evaluated in Cox proportional hazards models, with adjustment for sociodemographic factors, body mass index, smoking, comorbidity, tumor characteristics, and treatment. Differences among covariates were assessed with Pearson χ2 , Student t -tests and Wilcoxon Rank Sum tests. All statistical tests were two-sided.
During a median follow-up of 11 years, 724 deaths occurred overall, with 303 from breast cancer. Fifty-five percent of the women were categorized as drinkers with volume of alcohol consumption ranging from 0.75 to 36.00 drinks/week. In multivariable models, a decreased risk of other-cause mortality was associated with low alcohol drinking (0.75-3.75 drinks/week; HR = 0.61, 95% CI = 0.47-0.78), moderate volume alcohol drinking (4.00-9.75 drinks/week; HR = 0.57, 95% CI = 0.39-0.85) and low frequency (0.75-3.75 drinks/week) beer and wine intake (HR = 0.69, 95% CI = 0.50-0.96 and HR = 0.68, 95% CI = 0.52-0.88 respectively). Although the risk of breast cancer-specific mortality was not statistically significantly associated with moderate (4.00-9.75 drinks/week) and high volume (10.00-36.00 drinks/week) alcohol drinking in the overall cohort (HR = 1.43, 95% CI = 95% 0.97-2.12 and HR = 1.53, 95% CI = 0.87-2.70 respectively), there was a positive association of alcohol consumption with breast cancer-specific mortality among current smokers (HR = 1.92, 95% CI = 1.03-3.57; Pinteraction = 0.04).
In this prospective cohort study, regular consumption of 0.75-36.00 alcoholic drinks per week during the year prior to breast cancer diagnosis was associated with a reduction in other-cause mortality and with an increase in breast cancer-specific mortality among current smokers, after taking into account clinical and sociodemographic factors.
确定乳腺癌诊断前饮酒与乳腺癌患者队列中因乳腺癌及其他原因导致的长期死亡率之间的关联。
我们研究了密歇根州一个由939名年龄在40 - 84岁的女性组成的队列,她们提供了关于诊断前饮酒类型、量和强度的完整信息。基于乳腺癌诊断前一年的每周饮酒量评估饮酒与死亡率的关联,在Cox比例风险模型中进行评估,并对社会人口学因素、体重指数、吸烟、合并症、肿瘤特征和治疗进行调整。使用Pearson χ2检验、Student t检验和Wilcoxon秩和检验评估协变量之间的差异。所有统计检验均为双侧检验。
在中位随访11年期间,共发生724例死亡,其中303例死于乳腺癌。55%的女性被归类为饮酒者,每周饮酒量在0.75至36.00杯之间。在多变量模型中,低量饮酒(0.75 - 3.75杯/周;风险比[HR]=0.61,95%置信区间[CI]=0.47 - 0.78)、中等量饮酒(4.00 - 9.75杯/周;HR = 0.57,95% CI = 0.39 - 0.85)以及低频率(0.75 - 3.75杯/周)饮用啤酒和葡萄酒与其他原因导致的死亡率降低相关(HR分别为0.69,95% CI = 0.50 - 0.96和HR = 0.68,95% CI = 0.52 - 0.88)。尽管在整个队列中,中等量(4.00 - 9.75杯/周)和高量(10.00 - 36.00杯/周)饮酒与乳腺癌特异性死亡率之间无统计学显著关联(HR分别为1.43,95% CI = 0.97 - 2.12和HR = 1.53,95% CI = 0.87 - 2.70),但在当前吸烟者中,饮酒与乳腺癌特异性死亡率呈正相关(HR = 1.92,95% CI = 1.03 - 3.57;交互作用P值 = 0.04)。
在这项前瞻性队列研究中,考虑临床和社会人口学因素后,乳腺癌诊断前一年每周规律饮用0.75 - 36.00杯酒精饮料与其他原因导致的死亡率降低相关,而在当前吸烟者中与乳腺癌特异性死亡率升高相关。